At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
CP950 Sound Processor +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Usability of the CP950 Sound Processor With Experienced Cochlear Implant Users
In Brief
A clinical study evaluating CP950 Sound Processor and Wireless programming pod for Hearing Loss. Completed, enrolled 30 participants across 3 sites.
Detailed Summary
Studying usability and gaining feedback of the CP950 Sound Processor in experienced cochlear implant recipients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedApr 2016
Primary CompletionDec 2016
TodayJul 2026
First PostedApr 5, 2016
Enrollment StartApr 1, 2016
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.2 years ago
Interventions
CP950 Sound Processordevice
An off-the-ear processor configuration with identical functionality to the commercially approved CP910/920 processor
Wireless programming poddevice
The CP950 Sound Processor will be programmed by the wireless programming pod, which is needed as the interface to commercially approved programming software